Expensive care - a rationale for economic evaluations in intensive care

Research output: Contribution to journalArticleOther

5 Citations (Scopus)

Abstract

The demand for intensive care services is growing, and the cost of these services is increasing, with newer technologies consuming larger portions of the health care budget. We contend that both the costs and benefits of interventions must be considered to truly understand their value in critical care. Economic evaluations provide an explicit framework to compare the costs and benefits of an intervention. If these factors are not considered together, decisions may be made that do not result in the most efficient use of constrained resources. Despite limitations arising from variations in economic evaluation methodology, logistical complexity and problems of generalisability, the Australian trial environment provides an ideal opportunity to obtain robust economic data to help decision-making. Here, we outline the rationale for conducting economic evaluations in the critical care setting and argue that these evaluations need to be routinely incorporated into all large-scale clinical trials.
Original languageEnglish
Pages (from-to)62 - 66
Number of pages5
JournalCritical Care and Resuscitation
Volume12
Issue number1
Publication statusPublished - 2010

Cite this

@article{875d9f17a5f640eaa743554d7238e8f7,
title = "Expensive care - a rationale for economic evaluations in intensive care",
abstract = "The demand for intensive care services is growing, and the cost of these services is increasing, with newer technologies consuming larger portions of the health care budget. We contend that both the costs and benefits of interventions must be considered to truly understand their value in critical care. Economic evaluations provide an explicit framework to compare the costs and benefits of an intervention. If these factors are not considered together, decisions may be made that do not result in the most efficient use of constrained resources. Despite limitations arising from variations in economic evaluation methodology, logistical complexity and problems of generalisability, the Australian trial environment provides an ideal opportunity to obtain robust economic data to help decision-making. Here, we outline the rationale for conducting economic evaluations in the critical care setting and argue that these evaluations need to be routinely incorporated into all large-scale clinical trials.",
author = "Alisa Higgins and Pettila, {Ville Yrjo Olavi} and Rinaldo Bellomo and Harris, {Anthony H} and Nichol, {Alistair Dualta} and Siouxzy Morrison",
year = "2010",
language = "English",
volume = "12",
pages = "62 -- 66",
journal = "Critical Care and Resuscitation",
issn = "1441-2772",
publisher = "Australasian Medical Publishing Co. Pty Ltd. (AMPCo)",
number = "1",

}

TY - JOUR

T1 - Expensive care - a rationale for economic evaluations in intensive care

AU - Higgins, Alisa

AU - Pettila, Ville Yrjo Olavi

AU - Bellomo, Rinaldo

AU - Harris, Anthony H

AU - Nichol, Alistair Dualta

AU - Morrison, Siouxzy

PY - 2010

Y1 - 2010

N2 - The demand for intensive care services is growing, and the cost of these services is increasing, with newer technologies consuming larger portions of the health care budget. We contend that both the costs and benefits of interventions must be considered to truly understand their value in critical care. Economic evaluations provide an explicit framework to compare the costs and benefits of an intervention. If these factors are not considered together, decisions may be made that do not result in the most efficient use of constrained resources. Despite limitations arising from variations in economic evaluation methodology, logistical complexity and problems of generalisability, the Australian trial environment provides an ideal opportunity to obtain robust economic data to help decision-making. Here, we outline the rationale for conducting economic evaluations in the critical care setting and argue that these evaluations need to be routinely incorporated into all large-scale clinical trials.

AB - The demand for intensive care services is growing, and the cost of these services is increasing, with newer technologies consuming larger portions of the health care budget. We contend that both the costs and benefits of interventions must be considered to truly understand their value in critical care. Economic evaluations provide an explicit framework to compare the costs and benefits of an intervention. If these factors are not considered together, decisions may be made that do not result in the most efficient use of constrained resources. Despite limitations arising from variations in economic evaluation methodology, logistical complexity and problems of generalisability, the Australian trial environment provides an ideal opportunity to obtain robust economic data to help decision-making. Here, we outline the rationale for conducting economic evaluations in the critical care setting and argue that these evaluations need to be routinely incorporated into all large-scale clinical trials.

UR - http://www.cicm.org.au/journal_load.php?year=2010&month=march&page=62.html&title=62%20Expensive%20care%20-%20a%20rationale%20for%20economic%20evaluati

M3 - Article

VL - 12

SP - 62

EP - 66

JO - Critical Care and Resuscitation

JF - Critical Care and Resuscitation

SN - 1441-2772

IS - 1

ER -